Metronidazole use in malodorous skin lesions

Area of Science:

• Dermatology
• Infectious Diseases
• Oncology

Background:

• Malodorous skin lesions, such as fungating tumors and decubitus ulcers, present a significant challenge in patient care.
• Odor is often attributed to anaerobic bacteria, particularly Bacteroides species.
• Current treatments for odor control can be costly and associated with systemic side effects.

Purpose of the Study:

• To evaluate the efficacy of topical metronidazole in controlling odor associated with malodorous skin lesions.
• To explore potential benefits beyond odor reduction, such as wound appearance and pain management.

Main Methods:

• Application of topical metronidazole to malodorous skin lesions.
• Anecdotal reporting of odor control and wound characteristics.
• Observation of patient outcomes.

Main Results:

• Topical metronidazole demonstrated rapid and significant odor reduction, often within 24 hours.
• Some patients experienced improvements in wound appearance and a reduction in pain.
• No systemic side effects were reported.

Conclusions:

• Topical metronidazole is a promising agent for managing odor in malodorous skin lesions.
• Further clinical studies are warranted to confirm its efficacy and explore its full therapeutic potential.
• This approach offers a localized, cost-effective, and safe alternative to systemic treatments.